Assessment of frequency of HIV‐1 IN mutations and susceptibility of site‐directed mutant viruses containing major and minor INSTI‐R mutations in treatment naïve patients
Latest Information Update: 29 Jul 2020
At a glance
- Drugs Bictegravir (Primary) ; Dolutegravir (Primary) ; Elvitegravir (Primary) ; HIV integrase inhibitors (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Therapeutic Use
- 29 Jul 2020 New trial record